Bursa fabricius heptapeptide for promoting vaccine immunoreaction and application thereof
A technology of bursa polypeptide and bursa, which is applied in the field of active heptapeptide of bursa, can solve problems such as economic losses in poultry industry, hidden dangers of public health safety, threats to human health, etc., to promote extensive immune enhancement and simple structure , Improving the effect of vaccine immunity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] 1. Isolation and identification of BP7
[0028] 500 g AA broiler bursa tissue without fascia and adipose tissue was washed once with 0.85% normal saline (pre-chilled to 4-10°C). After draining, place the bursa tissue in a tissue masher, add pre-cooled normal saline, and homogenize at high speed three times for 30 seconds each time. The homogenization process is maintained at 0-10°C. The homogenate was then ultrasonically lysed twice at 4°C, 5 min / time. The lysate was then heated to 80°C for 5 min, then quickly placed on ice and cooled to 10°C. The lysate was then refrigerated and centrifuged for 30 minutes (4000 xg / min). The supernatant was collected and freeze-thawed twice. The supernatant was then centrifuged at high speed at 12000g / min, 4°C, 30min. The supernatant was collected for ultrafiltration, and the ultrafiltrate with a molecular weight below 1000 Da was collected, that is, the crude extract of the bursa tissue. After lyophilization, diluted with ultrapur...
Embodiment 2
[0030] 1. Synthesis of BP7
[0031] A commercial polypeptide synthesis company was entrusted to synthesize the polypeptide according to the GGCDGAA sequence (SEQ ID No. 1), and the purity was required to be ≧97%.
[0032] 2. Vaccines
[0033] AIV inactivated vaccine (purchased from Nanjing Tianbang Biotechnology Co., Ltd.)
[0034] 3. Grouping of experimental animals
[0035] BALB / C mice were randomly divided into five groups, 10 in each group: (I) PBS control group (each immunized with 0.2ml PBS); (II) AIV inactivated vaccine immunization group (each immunized with inactivated vaccine 0.2ml) ); (III-V) inactivated vaccine + BP7 group (BP9 concentrations were 10, 50, 250ug / mL, and the immunization dose was 0.2ml); the corresponding groups of mice were immunized twice by intraperitoneal injection. The immunization interval was two weeks, 200ul / every / every time (Table 1).
[0036] 4. Sample Collection of Immunized Mice
[0037] After the third immunization of mice, the orbi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com